Biologics for chronic rhinosinusitis

Overview of attention for article published in Cochrane database of systematic reviews, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 32 tweeters

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 129 Mendeley

Summary Twitter Facebook Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life

Article in Clinical and Molecular Allergy (May 2022)

Correlation of polyp grading scales with patient symptom scores and olfaction in chronic rhinosinusitis: a systematic review and meta-analysis

Article in Rhinology (April 2022)

Comparison of different biologics for treating chronic rhinosinusitis with nasal polyps: a network-analysis

Article in The Journal of Allergy and Clinical Immunology In Practice (March 2022)